Dimethylformamide diethylacetal → 3-(Dimethylamino)-2-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]acrylic acid methyl ester

HRID 876650노트

반응식

HRID 876650 반응식
[CH2:1]([O:3][C:4](=[O:15])[CH2:5][C:6]1[S:7][C:8]([C:11]([F:14])([F:13])[F:12])=[N:9][N:10]=1)C.C(O[CH:19](OCC)[N:20]([CH3:22])[CH3:21])C>>[CH3:1][O:3][C:4](=[O:15])[C:5]([C:6]1[S:7][C:8]([C:11]([F:14])([F:13])[F:12])=[N:9][N:10]=1)=[CH:19][N:20]([CH3:22])[CH3:21]

참가 물질

3

실험 절차

3.05 g (13.5 mmol) 5-(trifluoromethyl)-1,3,4-thiadiazol-2-ylacetic acid ethyl ester [for preparation see DE 42 40 168-A1] are heated in 6.9 ml (40.5 mmol) dimethylformamide diethyl acetal overnight at 100° C. After cooling, the mixture is concentrated and the residue is purified by means of preparative HPLC (RP18 column; mobile phase: acetonitrile/water gradient).

후처리

  1. temperatureAfter cooling
  2. concentrationthe mixture is concentrated
  3. customthe residue is purified by means of preparative HPLC (RP18 column; mobile phase: acetonitrile/water gradient)

출처 및 근거

ORD 기록
ord-ddfd1508350943c68a819e43870d8304
출처 데이터셋
uspto-grants-2015_03
특허 번호
US08987261B2

반응 노트

불러오는 중…